Adial Pharmaceuticals (ADIL) News Today → Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (From American Alternative) (Ad) Free ADIL Stock Alerts $1.71 +0.01 (+0.59%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAdial Pharmaceuticals secures new addiction treatment patentuk.investing.com - April 24 at 1:22 PMAdial Pharmaceuticals, Inc: Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Officefinanznachrichten.de - April 22 at 2:09 PMEXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patentbenzinga.com - April 22 at 9:09 AMAdial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Officeglobenewswire.com - April 22 at 8:30 AMWhy Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors' Radars Todaymsn.com - April 11 at 12:22 AMDow Falls Over 1%; US Inflation Rate Accelerates In Marchmsn.com - April 11 at 12:22 AMAdial Pharmaceuticals Shares Rise 78% After Positive Trial Data for AD04marketwatch.com - April 10 at 2:20 PMAdial stock rallies 81% on data for alcohol abuse drugmsn.com - April 10 at 2:20 PMWhy Is Adial Pharmaceuticals (ADIL) Stock Up 59% Today?investorplace.com - April 10 at 11:53 AMEXCLUSIVE: Adial Pharmaceuticals' Potential Treatment For Alcohol Use Disorder Shows Encouraging Safety, Patient Compliancemsn.com - April 10 at 9:20 AMAdial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorderfinance.yahoo.com - April 10 at 9:20 AMAdial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorderglobenewswire.com - April 10 at 8:30 AMAdial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Updateglobenewswire.com - April 2 at 8:30 AMAdial Pharmaceuticals Inc (ADIL)investing.com - March 19 at 8:57 AMMASI Apr 2024 120.000 callfinance.yahoo.com - March 16 at 9:15 AMMASI Apr 2024 125.000 putfinance.yahoo.com - March 16 at 9:15 AMPeering Into Adial Pharmaceuticals's Recent Short Interestbenzinga.com - March 11 at 8:16 PMAdial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceedsglobenewswire.com - March 1 at 7:00 PMAdial Pharmaceuticals secures new patent for AD04 druginvesting.com - March 1 at 8:50 AMWhy Adial Pharmaceuticals Stock Is Blasting Offmsn.com - February 28 at 7:16 PMAdial Pharmaceuticals, Inc: Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Officefinanznachrichten.de - February 28 at 2:16 PMEXCLUSIVE: Adial Pharmaceuticals Secures New US Patent Covering Lead Product For Alcohol Use Disorderfinance.yahoo.com - February 28 at 2:16 PMmarketbeat.com - February 28 at 9:47 AMAdial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Officeglobenewswire.com - February 28 at 9:30 AMAdial Pharmaceuticals, Inc.: Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20finanznachrichten.de - February 15 at 10:29 AMAdial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20finance.yahoo.com - February 15 at 10:29 AMAdial Pharmaceuticals, Inc: Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Officefinanznachrichten.de - February 13 at 5:35 PMAdial Pharma Shares Rise 26% After Patent Notice of Allowance for AD04marketwatch.com - February 13 at 12:35 PMEXCLUSIVE: Adial Pharmaceuticals Announces New US Patent Covering Its Molecular Genetic Diagnosing For Alcohol, Drug Dependencemsn.com - February 13 at 12:35 PMAdial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Officefinance.yahoo.com - February 13 at 12:35 PMAdial Pharmaceuticals, Inc: Adial Announces Appointment of Tony Goodman as Chief Operating Officerfinanznachrichten.de - January 18 at 1:20 PMAdial Pharmaceuticals Names Director Tony Goodman As Chief Operating Officermarkets.businessinsider.com - January 18 at 1:20 PMAdial Pharmaceuticals files for $100M mixed shelfmsn.com - January 12 at 6:50 PMAdial Pharmaceuticals, Inc: Adial Pharmaceuticals Receives Final Reimbursement Payment from Adovatefinanznachrichten.de - December 20 at 3:24 PMAdial Pharmaceuticals Receives Final Reimbursement Payment from Adovatefinance.yahoo.com - December 20 at 10:24 AMAdial Pharma Shares Rise After Regaining Nasdaq Listing Compliancemarketwatch.com - November 30 at 8:54 AMAdial Pharmaceuticals regains compliance with Nasdaq listing rulemsn.com - November 29 at 6:59 PMAdial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirementfinance.yahoo.com - November 29 at 6:59 PMAdial Pharmaceuticals, Inc: Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Updatefinanznachrichten.de - November 15 at 9:35 AMAdial Pharmaceuticals reports Q3 resultsmsn.com - November 14 at 11:08 PMAdial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - November 14 at 6:07 PMAdial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine Conferencefinance.yahoo.com - October 31 at 10:22 AMAll You Need to Know About Adial Pharmaceuticals, Inc. (ADIL) Rating Upgrade to Buyfinance.yahoo.com - October 30 at 5:39 PMAdial Pharmaceuticals, Inc: Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rulesfinanznachrichten.de - October 25 at 8:14 AMAddiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader Webinarfinance.yahoo.com - October 25 at 8:14 AMAdial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rulesfinance.yahoo.com - October 24 at 7:43 PMAdial Pharma Shares Drop 24% After Private Placement Pricesmarketwatch.com - October 21 at 7:43 PMAdial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rulesfinance.yahoo.com - October 20 at 9:21 AMAdial Pharma Shares Rise 5% After Patent Notice of Allowancemarketwatch.com - October 19 at 1:54 PMAdial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company’s Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug Dependencefinance.yahoo.com - October 19 at 1:54 PM Get Adial Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ADIL and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"... CLICK HERE TO GET YOUR GUIDE NOW ADIL Media Mentions By Week ADIL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADIL News Sentiment▼0.590.44▲Average Medical News Sentiment ADIL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADIL Articles This Week▼41▲ADIL Articles Average Week Get Adial Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ADIL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cadrenal Therapeutics News Protagenic Therapeutics News Tenax Therapeutics News Clever Leaves News Trevena News Can-Fite BioPharma News eFFECTOR Therapeutics News Enveric Biosciences News Shuttle Pharmaceuticals News Kazia Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADIL) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchGreat Crypto BullWeiss RatingsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adial Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
